Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children

Eur Neuropsychopharmacol
June 1999
https://www.ncbi.nlm.nih.gov/pubmed/?term=10422898

Naltrexone in autistic children: an acute open dose range tolerance trial

J Am Acad Child Adolesc Psychiatry
March 1989
http://www.ncbi.nlm.nih.gov/pubmed/?term=2925573

Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone

Encephale
Mar-Apr 1993
http://www.ncbi.nlm.nih.gov/pubmed/8275903

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children

Psychopharmacol Bull
1993
https://pubmed.ncbi.nlm.nih.gov/8290669/

Naltrexone and communication skills in young children with autism

J Am Acad Child Adolesc Psychiatry
May 1999
https://pubmed.ncbi.nlm.nih.gov/10230191/

Objective: To evaluate the effect of naltrexone on communication skills of young children with autism.

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design

J Autism Dev Disord
April 1999
https://pubmed.ncbi.nlm.nih.gov/10382138/

Naltrexone open trial with a 5-year-old-boy. A social rebound reaction

Acta Paedopsychiatr
1992
https://pubmed.ncbi.nlm.nih.gov/1414352/

Naltrexone and other potential new pharmacological treatments of autism

Brain Dysfunction
April 1991
https://psycnet.apa.org/record/1993-26766-001

Brian Udell, MD - Autism (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Udell's Autism Presentation

Dr Brian Udell has been treating patients with Autism since 1975 and opened his clinic in 2008 for developmentally delayed children. 

Brian Udell, MD - The Autism Spectrum (2017 Conference) (LDN, low dose naltrexone)